![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Wild, C. (2006): [Pegaptanib (Macugen®) for age-related macular degeneration (AMD)]. HTA-Newsletter 46: pp. 3-4.
Preview |
PDF (HTA-Newsletter 46)
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
131kB |
Official URL: http://hw.oeaw.ac.at/ita/hta-newsletter?frames=yes
| Item Type: | HTA Newsletter Item |
|---|---|
| Keywords: | Pegaptanib, Macugen®, age-related macular degeneration (AMD), drug therapy, vascular endothelial growth factor (VEGF), angiogenese inhibitor |
| Subjects: | WW Ophthalmology > WW 270 Retina |
| Related URLs: | |
| References: | 1. CCOHTA/CA 2005: Pegaptanib for neovascular age-related macular degeneration. URL: http://www.cadth.ca/media/pdf/367_pegaptanib_cetap_e.pdf. 2. NHSC/GB 2005: Ranibizumab for age-related macular degeneration – horizon scanning review. URL: http://pcpoh.bham.ac.uk/publichealth/horizon/PDF_files/ 2005reports/Ranibizumab.pdf. 3. NHSC/GB 2002: Pegaptanib for age-related macular degeneration – horizon scanning review. URL: http://pcpoh.bham.ac.uk/publichealth/horizon/PDF_files/ 2002reports/Pegaptinib.pdf. |
| Language: | German |
| Number: | 46 |
| Deposited on: | 21 Jan 2008 18:07 |
| Last Modified: | 15 Jul 2020 17:35 |
Repository Staff Only: item control page